SCHEMBL4139890

SCHEMBL4139890

COc1cc(-c2cnc(N)c(-c3nc4ccccc4n3CCN(C)C)n2)ccc1OCCN(C)C

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 4/20 0.50
HSD17B10 Q99714 2/20 0.50
RECQL P46063 1/20 0.50
ALDH1A1 P00352 3/20 0.46
TP53 P04637 2/20 0.46
SMN1; SMN2 Q16637 2/20 0.46
MAPT P10636 1/20 0.46
GAA P10253 1/20 0.46
NPC1 O15118 1/20 0.45
HPGD P15428 1/20 0.45
MAPK1 P28482 1/20 0.45
RAB9A P51151 1/20 0.45
EGFR P00533 3/20 0.43
ATR Q13535 3/20 0.42
NOS3 P29474 1/20 0.41
NOS1 P29475 1/20 0.41
CSF1R P07333 3/20 0.40
ADORA2A P29274 1/20 0.39
DRD2 P14416 1/20 0.39
DRD3 P35462 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4158549 0.82 MAP3K11 (0.50) KDM4EHSD17B10RECQLALDH1A1TP53
SCHEMBL3924773 0.82 EGFR (0.48) KDM4EHSD17B10RECQLALDH1A1TP53
SCHEMBL4010236 0.81 JAK2 (0.51) KDM4EHSD17B10RECQLALDH1A1TP53
SCHEMBL3928126 0.78 MCHR1 (0.47) KDM4EHSD17B10RECQLADORA2A
SCHEMBL221219 0.71 NOS1 (0.71) KDM4EALDH1A1SMN1; SMN2NPC1RAB9A
SCHEMBL1899791 0.70 RPS6KB1 (0.51) KDM4EALDH1A1TP53SMN1; SMN2MAPT
SCHEMBL13613482 0.69 KDM4E (0.67) KDM4EHSD17B10ALDH1A1TP53SMN1; SMN2
SCHEMBL3987482 0.68 KDM4E (0.52) KDM4EHSD17B10RECQLALDH1A1TP53
SCHEMBL3987496 0.68 HPGD (0.58) KDM4EHSD17B10RECQLALDH1A1TP53
SCHEMBL4006573 0.67 ATR (0.59) EGFRATR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009007390-A2 2-PYRAZ INYLBENZ IMIDAZOLE DERIVATIVES AS RECEPTOR TYROSINE KINASE INHIBITORS ASTRAZENECA AB (SE) 2009-01-15 WO claimed